SCHEMBL9535313

SCHEMBL9535313

O=C(OCc1ccccc1)N1CCC(S(=O)(=O)c2nc3ccccc3n2Cc2ccc(F)cc2)CC1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.47
CYP2C9 P11712 1/20 0.47
CYP1A2 P05177 1/20 0.47
TP53 P04637 2/20 0.46
HRH1 P35367 8/20 0.45
CYP2D6 P10635 7/20 0.45
CHRM1 P11229 3/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
GRIN2B Q13224 2/20 0.45
SSTR5 P35346 1/20 0.45
ALDH1A1 P00352 1/20 0.45
LMNA P02545 1/20 0.45
GAA P10253 1/20 0.45
KCNH2 Q12809 3/20 0.44
TRPC3 Q13507 1/20 0.44
TRPC7 Q9HCX4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9537373 0.81 TP53 (0.52) CYP2C19TP53HRH1CYP2D6SMN1; SMN2
SCHEMBL10803148 0.78 TP53 (0.47) CYP2C19CYP2C9CYP1A2TP53HRH1
SCHEMBL9539548 0.78 KCNH2 (0.61) CYP2C19CYP2C9CYP1A2TP53HRH1
SCHEMBL9540017 0.75 PKM (0.54) TP53HRH1CYP2D6CHRM1SMN1; SMN2
SCHEMBL9699718 0.73 HRH1 (0.56) TP53HRH1CYP2D6CHRM1KCNH2
SCHEMBL9266568 0.73 HRH1 (0.66) TP53HRH1CYP2D6SMN1; SMN2RAB9A
SCHEMBL9535563 0.73 TP53 (0.51) TP53HRH1CYP2D6CHRM1SMN1; SMN2
SCHEMBL15568741 0.72 ALDH1A1 (0.63) CYP2C19CYP2C9CYP1A2HRH1CYP2D6
SCHEMBL6995354 0.72 LMNA (0.71) CYP2C19CYP1A2TP53HRH1CYP2D6
SCHEMBL477255 0.72 SMN1; SMN2 (0.67) CYP2C19CYP2C9CYP2D6SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0151826-B1 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines JANSSEN PHARMACEUTICA N.V. (BE) 1993-03-31 EP disclosed
US-4839374-A TREATING ALLERGIES JANSSEN PHARMACEUTICA, N.V. (BE) 1989-06-13 US disclosed
EP-0151826-A1 4-[(Bicyclic heterocyclyl)-methyl and -hetero]-piperidines JANSSEN PHARMACEUTICA N.V. (BE) 1985-08-21 EP disclosed